![Johannes Nippgen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Johannes Nippgen worked as the Chief Medical Officer at Alphamab Oncology from 2021 to 2022.
He holds a doctorate degree from The Johannes Gutenberg University of Mainz and Julius-Maximilians-Universität Würzburg.
| Sociétés | Poste | Fin |
|---|---|---|
| ALPHAMAB ONCOLOGY | Directeur Technique/Scientifique/R&D | 01/02/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
The Johannes Gutenberg University of Mainz
 The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alphamab Oncology
 Alphamab Oncology BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in development manufacturing and commercialization of therapeutics for cancer treatment | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
